
Response rate higher among patients with HIV treated with dolutegravir compared with lopinavir/ritonavir.

Response rate higher among patients with HIV treated with dolutegravir compared with lopinavir/ritonavir.

Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients.

Fixed-dose combination tablet containing doravirine achieved viral suppression in HIV-1 infected treatment-naïve adults.

Immunization of cows induces rapid elicitation of broadly neutralizing antibodies to HIV.

Combination treatments well tolerated amongst study participants with HIV-1 infection.

Proper dosing of Vorinostat can help expose latent HIV.

Hand, foot, and mouth disease (HFMD) is a contagious viral infection common in infants and young children.

PrEP has been found to be effective in preventing HIV in high-risk populations.

Since their discovery in the 1950s, cephalosporins have become one of the largest classes of antibiotics.

Findings point towards an HIV vaccine that stimulates the production of these antibodies.

Investigators aim to determine whether Zika virus interferes with antiretroviral drugs that prevent mother-to-child transmission of HIV.

Report finds socioeconomic factors that increase vulnerability to HIV.

Voluntary medical male circumcision may help to reduce the spread of HIV.

Top news of the day from across the health care landscape.

The once-daily drug contains bictegravir and emtricitabine/tenofovir to treat adults with HIV-1.

Competition in HIV drug development affecting stock market.

Inhibiting particle release and infectivity could lead to a cure for HIV-1.

Antibiotic resistance is making gonorrhea increasingly harder to treat, the World Health Organization (WHO) warned in a recently published report.

Reports confirm 10 hepatitis A-related deaths in Detroit area over the past year.

Mathematical model brings scientists a step closer to developing total viral suppression strategies among patients with HIV.

Sharp Spike Underscores Need for New Treatments

New diagnoses and prevalence of HIV is illustrated by demographics, location, and social determinants of health.

Two common, inexpensive antimicrobials may have greater clinical benefit for patients with methicillin-resistant Staphylococcus areus (MRSA) skin abscesses than previously thought.

HIV disproportionately affects blacks and Latinos, who are less likely to receive ongoing care.

The National HIV Testing Day annual campaign takes place on June 27th.